Skip to content
Screener

Novavax NVAX Segment Reporting, Other Segment Item, Amount

Segment Reporting, Other Segment Item, Amount at other companies

PRA Group logo
PRA GroupPRAA
$35.48M-6.5%
ConocoPhillips logo
ConocoPhillipsCOP
$7.45B+42.3%
Matthews International logo
Matthews InternationalMATW
-$15.63M-883%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$25.48M+4,316%
Radiant Logistics logo
Radiant LogisticsRLGT
-$271K-113%
Microbot Medical logo
Microbot MedicalMBOT
$557K+7.3%

Segments

By segment

See full
Reportable Segment$223.17M+406%

Other financials

Income statement

See full
Revenue$56.7M-76.3%
Gross profit$42.5M-81.0%
Operating income-$54.9M-154%
Net income-$53.4M-150%
EPS (diluted)-$0.32-152%

Balance sheet

See full
Cash & equivalents$191.5M-24.5%
Total debt$297.3M+413%
Total equity-$190.7M-607%
Total assets$955.6M-28.5%

Cash flow

See full
Operating cash flow-$72.8M+42.9%
CapEx$588.0K+11.6%
Free cash flow-$73.4M+42.7%

Valuation

See full
Market cap$1.27B+0.5%
Enterprise value$1.38B+27.9%
P/S3.1×+1.9×

Profitability

See full
Gross margin78.6%-9.6pp
Operating margin-56.6%-89.2pp
Net margin-59.9%-99.1pp
FCF margin-59%-61.5pp

Returns & leverage

See full
Return on equity-238.6%—
Debt / equity1.5×—
Current ratio2.3×0.0×